Poster

Pharmacokinetics and Safety of RYKINDO® (Risperidone) for Extended-Release Injectable Suspension, a Novel Long-Acting Injectable Risperidone, in Patients With Schizophrenia and/or Schizoaffective Disorder

This randomized, open-label, relative bioavailability study comparatively evaluated the pharmacokinetics and safety of RYKINDO®, a novel long-acting risperidone administered biweekly (Q2W...

10/26/2023

Opioid Antagonists: Clinical Utility, Pharmacology, and Safety and Tolerability

Pharmacology, clinical uses, and safety/tolerability of FDA-approved opioid antagonists are reviewed. Opioid antagonists treat opioid overdose, alcohol/opioid use disorder, and opioid-ind...

10/26/2023

Outcomes From OASIS: Observational Study of Long-Acting Injectables in Schizophrenia

OASIS was an observational study that evaluated real-world outcomes of atypical long-acting injectable (aLAI) antipsychotics in patients with schizophrenia. Overall, CGI-S scores at basel...

10/26/2023

Patient Perspective on Idiopathic Hypersomnia: Impact on Quality of Life and Satisfaction With the Diagnostic Process and Management

This study assessed symptoms, impact, diagnosis, and management of idiopathic hypersomnia in US patients surveyed online. Most respondents reported they had been misdiagnosed before recei...

10/26/2023

Patient Perspectives of Meaningful Change in Major Depressive Disorder

Findings from qualitative interviews with 19 US adult patients with major depressive disorder (MDD) highlighted the episodic and heterogeneous nature of MDD, as well as the importance of ...

10/26/2023

Patient Perspectives on Major Depressive Disorder Care to Inform Patient-Centered Approaches

To better understand patients’ experiences and perceptions of their major depressive disorder (MDD) care, we designed a 21-item survey to capture patient perceptions of their MDD symptoms...

10/26/2023

Patient Preferences and Nocturnal Experiences With Oxybate Therapy for Narcolepsy: RESTORE Study Interim Analysis

RESTORE (NCT04451668), an ongoing open-label/switch study evaluating the safety/tolerability of once-nightly sodium oxybate (ON-SXB), included 2 questionnaires administered to participant...

10/26/2023

Olanzapine/Samidorphan Effects on Weight Gain: A Pooled Analysis of Phase 2 and 3 Randomized, Double-Blind Studies

This pooled post hoc analysis compared the effects of a combination of olanzapine and samidorphan (OLZ/SAM) versus olanzapine on body weight after 12 weeks of treatment in patients with s...

10/26/2023

Medical Management of Capgras Syndrome with Underlying Lewy Body Dementia in an Elderly Patient with Mild Cognitive Impairment

A case report to evaluate and discuss the underlying pathology associated with both Lewy Body Dementia and Capgras syndrome, as well as the medical management and subsequent interventions...

10/26/2023

Medication Burden in Patients With Major Depressive Disorder Enrolled in Medicare Advantage Plans.

This study assessed real-world antidepressant treatment patterns and medication burden among Medicare Advantage Prescription beneficiaries with major depressive disorder (MDD). Adherence ...

10/26/2023